A clinical trial was done at the University Teaching (Children's) Hospital on 20 children suffering from clinical pneumonias with a specific drug regime with pivampicillin suspension. Every child was re-examined after 7-10 days of discharge from hospital. Only one child developed diarrhoea. There was no significant adverse drug toxicity shown in the biomedical investigations. Pivampicillin, three times a day at a dosage of 175 mg t.d.s. was found to be therapeutically effective in the treatment of childhood pneumonias.
Get full access to this article
View all access options for this article.
References
1.
FoltzELWestJWBredowIHWallickH (1970) Clinical pharmacology of pivampicillin. Antimicrobial Agents and Chemotherapy10, 442
2.
GorbachHC (1973) Klinische Erfahrung mit pivampicillin zur oralen antibiotischen Behandlung von Infektionen der Atem-, Harn- und Gallenwege. Therapie Woche35, 2935
3.
JordanMCde MaineJBKirbyWMM (1970) Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrobial Agents and Chemotherapy10, 438
4.
JordheimO (1974) Pivampicillinbehandling av infeksjoner i urinveier og genitalia hos gynekologiske pasienter—clinisk vurdering. Tidsskrift for den norske Laegeforening94, 1390
5.
KhanAA (1966) Review of a year's paediatric admissions to the Kenyatta National Hospital, Nairobi, Kenya. Journal of Tropical Medicine69, 69
6.
KirbyWMMKindAC (1967) Clinical pharmacology of ampicillin and hetacillin. Annals of the New York Academy of Sciences145, 291
7.
KleinJOFinlandM (1963) Ampicillin activity in vitro and absorption and excretion in normal young men. American Journal of the Medical Sciences245, 544
